Every 37 seconds someone in the western world dies from a Venous thromboembolism (VTE).
New resource to support high-quality anticoagulation services during and beyond the pandemic
This article describes our new best practice framework service specification which is available to download free from Anticoagulation UK. The specification has been designed to support services to deliver best practice in anticoagulation diagnosis and management during and beyond the current pandemic.
Anticoagulation UK and Imperial College London Students produce leaflet for patients currently taking Direct Oral Anticoagulants (DOACs)
Anticoagulation UK launches 'best practice' framework service specification to support anticoagulation services
NICE VTE GUIDANCE
In March the National Institute for Health and Care Excellence published new NICE guidelines on VTE thromboembolic disease (NG 158)
Including an update on anticoagulation treatment for DVT or PE with active cancer.
During this uncertain time, Anticoagulation UK will be providing and sharing information and resources.
Some resources will be for patients and some for healthcare professionals.
Please, stay at home to stop coronavirus spreading. If you need medical help for any reason, do not go to places like a GP surgery, pharmacy or hospital.
If you have symptoms of coronavirus (a high temperature or a new continuous cough), use the 111 on-line coronavirus service. If your condition worsens and you have difficulty breathing use the 111 telephone service or dial 999
Resources section now available
Anticoagulation UK are pleased to announce the launch of our new online resources section.
Containing leaflets, reports and videos across a variety of topics for both patients and HCP's.
DEVELOPING OPTIMAL STANDARDS OF CARE FOR THE PREVENTION OF RECURRENT VENOUS THROMBOEMBOLISM (VTE): CONSENSUS STATEMENT
Anticoagulation UK's mission can be simply defined by 3 key objectives:
Watch the Film: Patients are never free from VTE
News & Events
07 April 2021
JCVI statement on use of the AstraZeneca COVID-19 vaccine
03 February 2021
Bayer receives approval in the UK for Rivaroxaban (Xarelto) to treat children with venous thromboembolism (VTE) and to prevent VTE recurrence
01 February 2021
Apple has warned that the magnets inside its new handset could interfere with medical devices such as pacemakers and defibrillators.
01 February 2021
New resource to support high-quality anticoagulation services during and beyond the pandemic
17 December 2020
COVID – 19 Vaccine and anticoagulants
16 December 2020
Anticoagulation UK guidance on the use of CBD oil for pain relief
07 December 2020
Are you a clinician managing patients on warfarin or a patient currently taking warfarin...
01 December 2020
Anticoagulation UK and Imperial College London Students produce leaflet for patients currently taking Direct Oral Anticoagulants (DOACs)
24 November 2020
COVID-19 rapid guideline: reducing the risk of venous thromboembolism in over 16s with COVID-19
13 October 2020
Advice to healthcare professionals and patients on the monitoring of patients taking blood thinning tablets
Page 1 of 7
Next
Get Social
Anticoagulation would love to hear from you.
Keep updated with all our activities across our social media platforms....
Your support makes our mission possible